Health ❯ Pharmaceuticals

Generic Drugs

Diabetes Treatment Market Dynamics Atorvastatin Semaglutide FDA Regulations US Government Programs Weight Loss GLP-1 Receptor Agonists Cancer Treatment US Market Impact

Generic Semaglutide Hits Canadian Pharmacy Shelves

Health Canada approvals and early shipments should cut costs and broaden access for patients across the country.

Stories older than 24h

Mexico Renews Warning as Counterfeit GLP-1 Weight-Loss Drugs Spread Worldwide

India Rolls Out Low-Cost Semaglutide Generics After Patent Expiry

Semaglutide Patent Expires in Brazil, Opening Door to Lower-Cost Rivals

Canada Opens Path to Generic Ozempic as Health Canada Weighs Nine Applications

FDA Class II Recall Issued for 141,984 Bottles of Generic Atorvastatin Over Dissolution Failures

FDA Class II Recall Targets 142,000 Bottles of Ascend’s Atorvastatin

FDA Confirms Safety Review of Mifepristone With No Regulatory Changes Yet

UK ‘Postcode Lottery’ for Weight-Loss Jabs Persists as Generics Line Up for 2026

Chinese Weight-Loss Drug Suppliers Pivot to Generics as U.S. Crackdown Ends Copycat Boom

EU Fines Teva $503 Million for Blocking MS Drug Competition